AZoLifeSciences on MSN
Genomic test can accurately identify early recurrence risk in prostate cancer patients
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...
Researchers will test the drugs against the disease after finding prostate cancer cells were more likely to duplicate and ...
The new research introduces a different strategy: rather than trying to overcome resistance, the scientists use it as a ...
6don MSNOpinion
Kentucky can lead the nation in the next revolution of early cancer detection | Opinion
OpEd: Multicancer early detection is the next frontier in cancer prevention and treatment, and it needs to be adopted widely.
Study Finds on MSN
Viral Protein Found In Cancer, Lupus, ALS Traced To Infection From Millions Of Years Ago
Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...
From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...
Every once in a while, a secular trend is so obvious that everyone can see it, and that is the case with AI. Read more here.
Mississippi has received over $205 million from the Centers for Medicare & Medicaid Services to improve health care in rural ...
Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into ...
Doctors and researchers warn that oesophageal cancer remains one of Kenya’s deadliest malignancies due to late diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results